Works in Leukemia & Lymphoma, 2017, Vol 58, Issue 10

Results: 37
    1
    2
    3
    4
    5

    Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 10, p. 2319, doi. 10.1080/10428194.2017.1312379
    By:
    • Skamene, Tanya;
    • Crump, Michael;
    • Savage, Kerry J.;
    • Reiman, Tony;
    • Kuruvilla, John;
    • Good, David;
    • LeBrun, David;
    • Meyer, Ralph M.;
    • Sehn, Laurie H.;
    • Soulières, Denis;
    • Stakiw, Julie;
    • Laferriere, Nicole;
    • Luminari, Stefano;
    • Shepherd, Lois E.;
    • Djurfeldt, Marina;
    • Zhu, Liting;
    • Chen, Bingshu E.;
    • Hay, Annette E.
    Publication type:
    Article
    6
    7
    8
    9
    10

    Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup.

    Published in:
    2017
    By:
    • Ludwig, Heinz;
    • Dimopoulos, Meletios A.;
    • Moreau, Philippe;
    • Chng, Wee-Joo;
    • Goldschmidt, Hartmut;
    • Hájek, Roman;
    • Facon, Thierry;
    • Pour, Ludek;
    • Niesvizky, Ruben;
    • Oriol, Albert;
    • Rosiñol, Laura;
    • Suvorov, Aleksandr;
    • Gaidano, Gianluca;
    • Pika, Tomas;
    • Weisel, Katja;
    • Goranova-Marinova, Vesselina;
    • Palumbo, Antonio;
    • Gillenwater, Heidi H.;
    • Mohamed, Nehal;
    • Aggarwal, Sanjay
    Publication type:
    Letter to the Editor
    11
    12

    Report of the 6th International Workshop on PET in lymphoma.

    Published in:
    2017
    By:
    • Nanni, Cristina;
    • Cottereau, Anne Ségolène;
    • Lopci, Egesta;
    • Bodet-Milin, Caroline;
    • Coronado, Monica;
    • Pro, Barbara;
    • Kim, Wong Seog;
    • Trotman, Judith;
    • Barrington, Sally;
    • Duhrsen, Ulrich;
    • Vander Borght, Thierry;
    • Zamagni, Elena;
    • Kraeber-Bodéré, Françoise;
    • Messiou, Christina;
    • Rahmouni, Alain;
    • Buvat, Irène;
    • Andre, Marc;
    • Hertzberg, Mark;
    • Oyen, Wim;
    • Casasnovas, Olivier
    Publication type:
    Conference Paper/Materials
    13

    A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 10, p. 2310, doi. 10.1080/10428194.2017.1298751
    By:
    • Sborov, Douglas W.;
    • Canella, Alessandro;
    • Hade, Erinn M.;
    • Mo, Xiaokui;
    • Khountham, Soun;
    • Wang, Jiang;
    • Ni, Wenjun;
    • Poi, Ming;
    • Coss, Christopher;
    • Liu, Zhongfa;
    • Phelps, Mitch A.;
    • Mortazavi, Amir;
    • Andritsos, Leslie;
    • Baiocchi, Robert A.;
    • Christian, Beth A.;
    • Benson, Don M.;
    • Flynn, Joseph;
    • Porcu, Pierluigi;
    • Byrd, John C.;
    • Pichiorri, Flavia
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG).

    Published in:
    2017
    By:
    • Iskierka-Jażdżewska, Elżbieta;
    • Hus, Marek;
    • Giannopoulos, Krzysztof;
    • Mądro, Elżbieta;
    • Hołojda, Jadwiga;
    • Piotrowska, Magdalena;
    • Zaucha, Jan M.;
    • Piszczek, Weronika;
    • Szeremet, Agnieszka;
    • Wojciechowska, Małgorzata;
    • Steckiewicz, Paweł;
    • Knopińska-Posłuszny, Wanda;
    • Osowiecki, Marek;
    • Drozd-Sokołowska, Joanna;
    • Kumiega, Beata;
    • Kyrcz-Krzemień, Sławomira;
    • Hałka, Janusz;
    • Dudziński, Marek;
    • Wieszczy, Paulina;
    • Robak, Tadeusz
    Publication type:
    Letter to the Editor
    31
    32
    33
    34
    35

    Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 10, p. 2356, doi. 10.1080/10428194.2017.1285027
    By:
    • Vojdeman, Fie J.;
    • Herman, Sarah E. M.;
    • Kirkby, Nikolai;
    • Wiestner, Adrian;
    • van t' Veer, Mars B.;
    • Tjønnfjord, Geir E.;
    • Itälä-Remes, Maija A.;
    • Kimby, Eva;
    • Farooqui, Mohammed Z.;
    • Polliack, Aaron;
    • Wu, Ka Lung;
    • Doorduijn, Jeanette K.;
    • Alemayehu, Wendimagegn G.;
    • Wittebol, Shulamiet;
    • Kozak, Tomas;
    • Walewski, Jan;
    • Abrahamse-Testroote, Martine C. J.;
    • van Oers, Marinus H. J.;
    • Geisler, Christian H.;
    • Niemann, Carsten U.
    Publication type:
    Article
    36
    37

    Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia – first findings of the OPAL trial.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 10, p. 2363, doi. 10.1080/10428194.2017.1280605
    By:
    • Krull, Kathinka;
    • Kunstreich, Marina;
    • Klasen-Sansone, Janina;
    • Kloetgen, Andreas;
    • Gruener, Franziska;
    • Escherich, Gabriele;
    • Bleckmann, Kirsten;
    • Moericke, Anja;
    • Schrappe, Martin;
    • Jorch, Norbert;
    • Steinbach, Daniel;
    • Classen, Carl-Friedrich;
    • Guggemos, Andreas;
    • Kolb, Reinhard;
    • Klee, Dirk;
    • Borkhardt, Arndt;
    • Kuhlen, Michaela
    Publication type:
    Article